212 related articles for article (PubMed ID: 31857074)
21. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
22. Allele-specific endogenous tagging and quantitative analysis of β-catenin in colorectal cancer cells.
Ambrosi G; Voloshanenko O; Eckert AF; Kranz D; Nienhaus GU; Boutros M
Elife; 2022 Jan; 11():. PubMed ID: 35014953
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
Gougelet A; Sartor C; Senni N; Calderaro J; Fartoux L; Lequoy M; Wendum D; Talbot JN; Prignon A; Chalaye J; Imbeaud S; Zucman-Rossi J; Tordjmann T; Godard C; Bossard P; Rosmorduc O; Amaddeo G; Colnot S
Gastroenterology; 2019 Sep; 157(3):807-822. PubMed ID: 31194980
[TBL] [Abstract][Full Text] [Related]
24. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
[TBL] [Abstract][Full Text] [Related]
26. Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium.
Feng Y; Sakamoto N; Wu R; Liu JY; Wiese A; Green ME; Green M; Akyol A; Roy BC; Zhai Y; Cho KR; Fearon ER
PLoS Genet; 2015 Nov; 11(11):e1005638. PubMed ID: 26528816
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma.
Iwai S; Katagiri W; Kong C; Amekawa S; Nakazawa M; Yura Y
J Cancer Res Clin Oncol; 2005 Dec; 131(12):773-82. PubMed ID: 16163548
[TBL] [Abstract][Full Text] [Related]
28. MGAT1 is a novel transcriptional target of Wnt/β-catenin signaling pathway.
Akiva I; Birgül Iyison N
BMC Cancer; 2018 Jan; 18(1):60. PubMed ID: 29310626
[TBL] [Abstract][Full Text] [Related]
29. Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice.
Zhang Y; Liang B; Song X; Wang H; Evert M; Zhou Y; Calvisi DF; Tang L; Chen X
Am J Pathol; 2021 May; 191(5):930-946. PubMed ID: 33545120
[TBL] [Abstract][Full Text] [Related]
30. Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration.
Phesse TJ; Buchert M; Stuart E; Flanagan DJ; Faux M; Afshar-Sterle S; Walker F; Zhang HH; Nowell CJ; Jorissen R; Tan CW; Hirokawa Y; Eissmann MF; Poh AR; Malaterre J; Pearson HB; Kirsch DG; Provero P; Poli V; Ramsay RG; Sieber O; Burgess AW; Huszar D; Vincan E; Ernst M
Sci Signal; 2014 Sep; 7(345):ra92. PubMed ID: 25270258
[TBL] [Abstract][Full Text] [Related]
31. Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis.
Debebe A; Medina V; Chen CY; Mahajan IM; Jia C; Fu D; He L; Zeng N; Stiles BW; Chen CL; Wang M; Aggarwal KR; Peng Z; Huang J; Chen J; Li M; Dong T; Atkins S; Borok Z; Yuan W; Machida K; Ju C; Kahn M; Johnson D; Stiles BL
Oncogene; 2017 Oct; 36(43):6020-6029. PubMed ID: 28671671
[TBL] [Abstract][Full Text] [Related]
32. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17216-21. PubMed ID: 15563600
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of colon tumors induced by a dietary carcinogen PhIP in CYP1A humanized mice: Identification of mutation of β-catenin/Ctnnb1 as the driver gene for the carcinogenesis.
Wang H; Zhou H; Liu A; Guo X; Yang CS
Mol Carcinog; 2015 Nov; 54(11):1264-74. PubMed ID: 25131582
[TBL] [Abstract][Full Text] [Related]
34. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS
J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
[TBL] [Abstract][Full Text] [Related]
35. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
36. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin.
Tao J; Xu E; Zhao Y; Singh S; Li X; Couchy G; Chen X; Zucman-Rossi J; Chikina M; Monga SP
Hepatology; 2016 Nov; 64(5):1587-1605. PubMed ID: 27097116
[TBL] [Abstract][Full Text] [Related]
37. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
[TBL] [Abstract][Full Text] [Related]
38. Wnt/β-Catenin Signaling Regulates the Expression of the Ammonium Permease Gene RHBG in Human Cancer Cells.
Merhi A; De Mees C; Abdo R; Victoria Alberola J; Marini AM
PLoS One; 2015; 10(6):e0128683. PubMed ID: 26029888
[TBL] [Abstract][Full Text] [Related]
39. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]